[Clinical experiences with anticoagulant therapy in children with consumption coagulopathies].
D000293:Adolescent; D000347:Afibrinogenemia / Q000188:drug therapy; D000925:Anticoagulants / Q000627:therapeutic use*; D001778:Blood Coagulation Disorders / Q000188:drug therapy*; D001780:Blood Coagulation Tests; D002648:Child; D002675:Child, Preschool; D005078:Exchange Transfusion, Whole Blood; D005260:Female; D005340:Fibrinogen / Q000627:therapeutic use; D006452:Hemoglobinometry; D006461:Hemolysis; D006493:Heparin / Q000008:administration & dosage; D006801:Humans; D007223:Infant; D007263:Infusions, Parenteral; D008297:Male; D008589:Meningococcal Infections / Q000188:drug therapy; D011693:Purpura / Q000188:drug therapy; D012156:Reticulocytes; D018805:Sepsis / Q000188:drug therapy; D013921:Thrombocytopenia / Q000150:complications; D014511:Uremia / Q000150:complications / Q000188:drug therapy; D014884:Waterhouse-Friderichsen Syndrome / Q000188:drug therapy
D000925:Anticoagulants; D005340:Fibrinogen; D006493:Heparin
Klinische Erfahrungen mit Antikoagulantientherapie bei Kindern mit Verbrauchskoagulopathien.